Tisch Cancer Institute at Mount Sinai
Retrospective Head-to-Head Comparison Between Pacritinib and Ruxolitinib in Patients With Myelofibrosis and Moderate-to-Severe Thrombocytopenia
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
John Mascarenhas
By
ASH 2021 Conference Coverage on VuMedi
FEATURING
John Mascarenhas
Login to view comments.
Click here to Login
Videos